June 26, 2022

Medical Trend

Medical News and Medical Resources

Many countries suspended AstraZeneca COVID-19 vaccine

Many countries suspended AstraZeneca COVID-19 vaccine



 

Many countries suspended AstraZeneca COVID-19 vaccine.  Worries about serious side effects, many countries suspend vaccination of AstraZeneca’s COVID-19 vaccine.

 

Many countries suspended AstraZeneca COVID-19 vaccine

 

The Danish National Health Service announced on the 11th that it would suspend vaccination of the COVID-19 vaccine jointly developed by the British AstraZeneca Pharmaceutical Company and the University of Oxford.

The suspension time is 14 days. The reason is that many people have thrombosis shortly after receiving the AstraZeneca COVID-19 vaccine. Among them are One person developed a blood clot after vaccination and died.

 

On the same day, some European countries announced a complete or partial suspension of AstraZeneca’s COVID-19 vaccine, but some countries said that they will continue to promote AstraZeneca’s COVID-19 vaccine.

 

The Norwegian Institute of Public Health issued a statement on the official website on the 11th, saying that due to a report from Denmark that one person died after being vaccinated with AstraZeneca’s COVID-19 vaccine, Norway will suspend vaccination of the vaccine for the public from now on.

The Executive Director of the Department of Infectious Disease Control and Environmental Health of the Institute of Public Health, Gil Bukholm, said in a statement that although the causal relationship between AstraZeneca’s COVID-19 vaccine and thrombotic death in the current Danish case has not been confirmed, it is used as a preventive measure.

Means, Norway chose to suspend vaccination of AstraZeneca’s COVID-19 vaccine during the European Medicines Agency investigation.

 

The Italian Medicines Agency said in a statement on the 11th that due to the recent reports of severe side effects in Italy and other European countries, it has decided to suspend the “ABV2856” batch of AstraZeneca’s COVID-19 vaccine in Italy, and if necessary, it will The European Medicines Agency cooperates closely.

The statement said that this decision was based on preventive considerations, and no causal relationship between serious side effects and vaccination has been found.

The Italian Institute of Advanced Health will begin to analyze samples of related batches of vaccines.

 

The Romanian National Coordinating Committee for COVID-19 Vaccination decided on the evening of the 11th to suspend the use of the “ABV2856” batch of AstraZeneca’s COVID-19 vaccine.

According to the communiqué issued by the committee that night, Romania received the first batch of 81,600 doses of AstraZeneca vaccine on February 7.

More than 77,000 doses have been used, and the remaining vaccines will be sealed and wait for European drug management. Bureau’s assessment report.

Romania’s decision is a prudent measure taken after Italy reported that the batch of vaccines may cause serious side effects.

 

Affected by the suspension of AstraZeneca’s COVID-19 vaccination incident in many European countries, the Thai government announced on March 12 that it will suspend the AstraZeneca COVID-19 vaccination plan originally scheduled to start on the same day.

Thai Prime Minister Prayut and a number of cabinet members also postponed the AstraZeneca COVID-19 vaccination originally scheduled for that day.

 

Previously, the Austrian Ministry of Health had suspended the vaccination of the “ABV5300” batch of AstraZeneca’s nCOVID-19 vaccine on the 7th, because an Austrian female nurse died of severe blood clotting disorder after receiving the AstraZeneca COVID-19 vaccine, and another was vaccinated with the same batch.

The medical staff of the vaccine was hospitalized for pulmonary embolism. The Austrian Ministry of Health stated that it has launched an investigation.

 

However, the Austrian Ministry of Health said on the 11th that it will continue to carry out AstraZeneca’s COVID-19 vaccination work instead of a complete suspension like Norway and Denmark.

 

The relevant British institutions also indicated that they will continue to promote AstraZeneca’s COVID-19 vaccine. The British Medicines and Health Products Administration said on the 11th that British people should still go to relevant locations for vaccination after being notified.

Phil Bryan, the chief expert on vaccine safety at the Medicines and Health Products Administration of the United Kingdom, said in a statement that it has not been confirmed that the blood clots of some people after being vaccinated in Denmark have not been confirmed to be caused by the vaccine.

The decision of the Danish authorities was only a preventive measure during the investigation. The British authorities will continue to evaluate the situation。

 

 

 

 

 

Many countries suspended AstraZeneca COVID-19 vaccine

(source:internet, reference only)


Disclaimer of medicaltrend.org